Skip to main content
Main navigation
Resources
Economic Reports
Policy Priorities
Profiles in Leadership
Published Bylines
Supplements to Savings
Consumer Data
CRN Experts/Members Explain
Take 5 Video Series
4 Things to Know Video Series
CRN Member Company Brands and Branded Ingredients
Fact Sheets
Be Label Wise
Regulation/Legislation
Self-Regulation
FDA/FTC Regulations
Comments/Legal Action
Legislation/Advocacy
Day on the Hill
Newsroom
For Media
Press Releases
Events/Education
Signature Events
Webinars/Live Q&A
Committees
—STANDING COMMITTEES
Communications, Marketing & Media Outreach
Government Relations
International Trade & Market Development
Legal
Membership
Regulatory Affairs Committee
Retailer Relations Forum
Senior Scientific Advisory Council
—WORKING GROUPS, ETC
Membership
Join CRN
Our Members
Our Board of Directors
Profiles in Leadership
CRN Staff
CRN Committees
The CRN SUPPLEMENT
Self-service Member Portal
Search
Search
Search
User account menu
Log in
Toggle navigation
User account menu
Log in
Secondary Navigation
About CRN
Contact Us
Main navigation
Resources
Economic Reports
Policy Priorities
Profiles in Leadership
Published Bylines
Supplements to Savings
Consumer Data
CRN Experts/Members Explain
Take 5 Video Series
4 Things to Know Video Series
CRN Member Company Brands and Branded Ingredients
Fact Sheets
Be Label Wise
Regulation/Legislation
Self-Regulation
Code of Ethics
The Supplement OWL
Voluntary Guidelines/Best Practices
Caffeine
Enzymes
Iodine
Melatonin
Probiotics
Protein
SARMs
Safe Upper Levels
FDA/FTC Regulations
Dietary Supplement Health & Education Act (DSHEA)
Key Regulations
Product Claims
Comments/Legal Action
Legislation/Advocacy
Economic Impact Study of the Dietary Supplement Industry
Multivitamins & SNAP Benefit
Supplements & Tax Policy
CRN Political Action Committee
Day on the Hill
Newsroom
For Media
Press Releases
Events/Education
Signature Events
Webinars/Live Q&A
Committees
—STANDING COMMITTEES
Communications, Marketing & Media Outreach
Government Relations
International Trade & Market Development
Legal
Membership
Regulatory Affairs Committee
Retailer Relations Forum
Senior Scientific Advisory Council
—WORKING GROUPS, ETC
Membership
Join CRN
Our Members
Our Board of Directors
Profiles in Leadership
CRN Staff
CRN Committees
The CRN SUPPLEMENT
Self-service Member Portal
Secondary Navigation
About CRN
Association Leadership
Code of Ethics
CRN Foundation
CRN-International
Contact Us
Home
crn submits comments status vinpocetine docket no fda 2016 n 2523
CRN Submits Comments on Status of Vinpocetine - Docket No. FDA-2016–N–2523
Comments - FDA
November 7, 2016 |
Download comments (PDF)
